Tilia Fiduciary Partners Inc. Buys 136 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tilia Fiduciary Partners Inc. raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,786 shares of the healthcare conglomerate’s stock after acquiring an additional 136 shares during the quarter. Tilia Fiduciary Partners Inc.’s holdings in UnitedHealth Group were worth $1,915,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. VitalStone Financial LLC lifted its position in shares of UnitedHealth Group by 600.0% in the second quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 60 shares during the last quarter. Linscomb Wealth Inc. lifted its holdings in UnitedHealth Group by 11.1% during the 2nd quarter. Linscomb Wealth Inc. now owns 1,054 shares of the healthcare conglomerate’s stock valued at $537,000 after purchasing an additional 105 shares during the last quarter. Qsemble Capital Management LP raised its position in shares of UnitedHealth Group by 161.3% in the second quarter. Qsemble Capital Management LP now owns 8,414 shares of the healthcare conglomerate’s stock valued at $4,285,000 after purchasing an additional 5,194 shares during the period. Johnson Investment Counsel Inc. grew its stake in UnitedHealth Group by 0.5% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 268,033 shares of the healthcare conglomerate’s stock valued at $136,499,000 after buying an additional 1,363 shares during the last quarter. Finally, BOKF NA lifted its position in UnitedHealth Group by 2.9% during the second quarter. BOKF NA now owns 66,217 shares of the healthcare conglomerate’s stock worth $33,722,000 after acquiring an additional 1,857 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 0.8 %

Shares of UNH traded down $4.41 during trading hours on Friday, reaching $520.11. The stock had a trading volume of 5,298,044 shares, compared to its average volume of 4,001,483. The company has a market capitalization of $478.65 billion, a price-to-earnings ratio of 33.88, a P/E/G ratio of 1.53 and a beta of 0.62. The firm has a 50-day simple moving average of $556.20 and a 200 day simple moving average of $561.20. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.56 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Barclays increased their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.